Prescription Drugs Archives - Page 2 of 5

Legal and Legislative Reporter: Court Denies Insurance Company’s Motion to Remand AD&D Benefits Claim

Guest Contributor

08 Feb 202310 Mar 2023

Every month, the International Foundation releases the Legal and Legislative Reporter, a compilation of new employee benefits-related case summaries. Below is a summary we thought you’d be interested in. Content provided by Morgan, Lewis & Bockius LLP. The U.S. District Court for the […]

Employee Benefits Employee Benefits Survey Health Care Prescription Drugs

Prescription Drug Cost-Containment Strategies

Justin Held, CEBS

12 Jan 202310 Mar 2023

According to a recent International Foundation survey report, health care costs are expected to increase by 7% between 2022 and 2021. This increase is driven by a number of factors, including the high cost of specialty prescription drugs. In response to the […]

Employee Benefits Employee Benefits Survey Prescription Drugs Wellness

Employers Covering Prescription Drugs for Weight Loss

Anne Patterson

05 Jan 202310 Mar 2023

A healthy reset has been a standard theme entering the new year, but it shouldn’t be the only time of year workplace wellness gets prioritized. What an individual’s weight says about their health status is an evolving discussion. So too is how […]

Employee Benefits Health Care Insurance Legislative Prescription Drugs Regulatory U.S.

RxDC Reporting Will Bring Changes . . . Here’s What to Know Now

Jonas Leyrer, CEBS

07 Dec 202207 Dec 2022

Late last year, Congress passed the Consolidated Appropriations Act, 2021 (CAA), which contained a provision requiring health care plans to submit Prescription Drug Data Collection (RxDC) reports to CMS. RxDC was made retroactive for 2020 but its implementation was delayed for a […]

Compliance Employee Benefits Health Care Insurance Legislative Prescription Drugs U.S.

Health Plans and Marijuana: What to Know Now

Kathy Bergstrom, CEBS

01 Dec 202227 Jan 2023

President Joe Biden is expected to sign a medical marijuana research bill that could eventually have an impact on health plan coverage of medical marijuana. On November 16, the U.S. Senate passed Medical Marijuana and Cannabidiol Research Act, which was passed by […]

Compliance Employee Benefits Health Care Insurance Prescription Drugs U.S.

RxDC Reporting: What Plan Sponsors Need to Know

Jonas Leyrer, CEBS

04 Nov 202204 Nov 2022

RxDC Overview In late 2021, Congress passed the Consolidated Appropriations Act, 2021 (CAA) which contained a provision that requires health care plans to submit Prescription Drug Data Collection (RxDC) reports to CMS. The new reporting requirement applies to most health insurance issuers […]

Compliance Disease Management Employee Benefits Health Care Human Resources (HR) Prescription Drugs U.S.

Four Steps for Evaluating Your Plan’s Diabetes Coverage

Kathy Bergstrom, CEBS

09 Aug 202209 Aug 2022

Despite major advancements in technology and medication over the last four decades, people with diabetes still face barriers to getting the best care, a panel of experts said during an International Foundation webcast. Better health plan design can help remove those barriers […]

Communication DOL Employee Benefits Health Care Insurance Legislative Prescription Drugs

Update on the No Surprises Act

Anne Newhouse

25 Jan 202225 Jan 2022

On December 27, 2020, the Consolidated Appropriations Act (CAA) of 2021 was signed into law and included the No Surprises Act (the Act). With so much guidance already published addressing the Act, the Department of Labor’s (DOL) Employee Benefits Security Administration (EBSA) […]

Employee Benefits Employee Benefits Survey Health Care Prescription Drugs U.S.

18 Prescription Drug Cost-Containment Strategies For Your Plan

Justin Held, CEBS

08 Jun 202107 Jun 2021

Benefits practitioners have grown accustomed to headlines addressing the escalating costs of prescription drug spending. Despite concerted efforts, the cost of commonly prescribed brand-name drugs continues to grow at alarming rates. A recent study from the University of Pittsburgh stated that over […]

Canada Coronavirus (COVID-19) Defined Benefit (DB) Plans Defined Contribution (DC) Plans Employee Assistance Program (EAP) Employee Benefits Mental Health Prescription Drugs Retirement

New Report: Impact of COVID-19 on Pensions and Benefits in Canada

Staff

04 May 202104 May 2021

The COVID-19 pandemic has had significant implications for workplaces across the world, and employers and workers have needed to make difficult decisions regarding retirement, health and paid leave benefits. A new International Foundation report, Impact of COVID-19 on Pensions and Benefits in Canada: […]